What is SeqOnce BioScience?
SeqOnce BioScience is a specialized provider of rapid and effective qPCR and library preparation kits, catering to researchers in the genomics field. Their product portfolio features advanced multiplexing qPCR kits and next-generation sequencing (NGS) products engineered for enhanced throughput and faster analytical outcomes. The company distinguishes itself through a commitment to robust technical assistance and responsive customer support, ensuring a seamless experience for its clientele. SeqOnce also integrates conservation efforts into its mission, leveraging its innovative assays and reagents to support the protection of endangered species.
How much funding has SeqOnce BioScience raised?
SeqOnce BioScience has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2018): $1M, investors not publicly disclosed
What's next for SeqOnce BioScience?
With a recent major strategic investment, SeqOnce BioScience is poised for accelerated growth and expanded market penetration. The capital infusion is expected to fuel further research and development, enhancing their existing suite of genomics tools and potentially leading to new product lines. This strategic backing will likely enable SeqOnce to scale its operations, increase its global reach, and solidify its position as a leader in providing high-throughput, rapid solutions for genomic analysis. The company's focus on both technological advancement and conservation initiatives suggests a forward-thinking approach to business development and corporate responsibility.
See full SeqOnce BioScience company page
